Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 104

1.

What 18F-FDG PET Response-Assessment Method Best Predicts Survival After Curative-Intent Chemoradiation in Non-Small Cell Lung Cancer: EORTC, PERCIST, Peter Mac Criteria, or Deauville Criteria?

Turgeon GA, Iravani A, Akhurst T, Beaulieu A, Callahan JW, Bressel M, Cole AJ, Everitt SJ, Siva S, Hicks RJ, Ball DL, Mac Manus MP.

J Nucl Med. 2019 Mar;60(3):328-334. doi: 10.2967/jnumed.118.214148. Epub 2018 Jul 20.

PMID:
30030343
2.

Dosimetric Consequences of 3D Versus 4D PET/CT for Target Delineation of Lung Stereotactic Radiotherapy.

Siva S, Chesson B, Callahan JW, Hardcastle N, Crawford L, Antippa P, Wright G, MacManus MP, Hicks RJ, Kron T, Ball DL.

J Thorac Oncol. 2015 Jul;10(7):1112-5. doi: 10.1097/JTO.0000000000000555.

3.

Relationship between subthalamic nucleus neuronal activity and electrocorticogram is altered in the R6/2 mouse model of Huntington's disease.

Callahan JW, Abercrombie ED.

J Physiol. 2015 Aug 15;593(16):3727-38. doi: 10.1113/JP270268. Epub 2015 Jun 25.

4.

Respiratory-gated (4D) FDG-PET detects tumour and normal lung response after stereotactic radiotherapy for pulmonary metastases.

Siva S, Callahan JW, Kron T, Chesson B, Barnett SA, Macmanus MP, Hicks RJ, Ball DL.

Acta Oncol. 2015;54(8):1105-12. doi: 10.3109/0284186X.2015.1027409. Epub 2015 Apr 2.

PMID:
25833329
5.

Age-dependent alterations in the cortical entrainment of subthalamic nucleus neurons in the YAC128 mouse model of Huntington's disease.

Callahan JW, Abercrombie ED.

Neurobiol Dis. 2015 Jun;78:88-99. doi: 10.1016/j.nbd.2015.03.006. Epub 2015 Mar 12.

PMID:
25772440
6.

Evaluation of N-nonyl-deoxygalactonojirimycin as a pharmacological chaperone for human GM1 gangliosidosis leads to identification of a feline model suitable for testing enzyme enhancement therapy.

Rigat BA, Tropak MB, Buttner J, Crushell E, Benedict D, Callahan JW, Martin DR, Mahuran DJ.

Mol Genet Metab. 2012 Sep;107(1-2):203-12. doi: 10.1016/j.ymgme.2012.06.007. Epub 2012 Jun 19.

7.

Reduced striatal acetylcholine efflux in the R6/2 mouse model of Huntington's disease: an examination of the role of altered inhibitory and excitatory mechanisms.

Farrar AM, Callahan JW, Abercrombie ED.

Exp Neurol. 2011 Dec;232(2):119-25. doi: 10.1016/j.expneurol.2011.08.010. Epub 2011 Aug 16.

PMID:
21864528
8.

In vivo Dopamine Efflux is Decreased in Striatum of both Fragment (R6/2) and Full-Length (YAC128) Transgenic Mouse Models of Huntington's Disease.

Callahan JW, Abercrombie ED.

Front Syst Neurosci. 2011 Jul 15;5:61. doi: 10.3389/fnsys.2011.00061. eCollection 2011.

9.

Distribution of proliferating bone marrow in adult cancer patients determined using FLT-PET imaging.

Hayman JA, Callahan JW, Herschtal A, Everitt S, Binns DS, Hicks RJ, Mac Manus M.

Int J Radiat Oncol Biol Phys. 2011 Mar 1;79(3):847-52. doi: 10.1016/j.ijrobp.2009.11.040. Epub 2010 May 14.

PMID:
20472367
10.

Identification of proteins in the ceroid-like autofluorescent aggregates from liver lysosomes of Beige, a mouse model for human Chediak-Higashi syndrome.

Zhang H, Mahuran DJ, Callahan JW.

Mol Genet Metab. 2010 Apr;99(4):389-95. doi: 10.1016/j.ymgme.2009.12.009. Epub 2009 Dec 21.

PMID:
20061169
11.

The integral membrane of lysosomes: its proteins and their roles in disease.

Callahan JW, Bagshaw RD, Mahuran DJ.

J Proteomics. 2009 Feb 15;72(1):23-33. doi: 10.1016/j.jprot.2008.11.007. Epub 2008 Nov 18. Review.

PMID:
19068244
12.

Cryptic splice site in the complementary DNA of glucocerebrosidase causes inefficient expression.

Bukovac SW, Bagshaw RD, Rigat BA, Callahan JW, Clarke JT, Mahuran DJ.

Anal Biochem. 2008 Oct 15;381(2):276-8. doi: 10.1016/j.ab.2008.06.029. Epub 2008 Jun 21.

PMID:
18619939
13.

Purification and proteomic analysis of lysosomal integral membrane proteins.

Zhang H, Fan X, Bagshaw R, Mahuran DJ, Callahan JW.

Methods Mol Biol. 2008;432:229-41. doi: 10.1007/978-1-59745-028-7_16.

PMID:
18370022
14.

Molecular consequences of the pathogenic mutation in feline GM1 gangliosidosis.

Martin DR, Rigat BA, Foureman P, Varadarajan GS, Hwang M, Krum BK, Smith BF, Callahan JW, Mahuran DJ, Baker HJ.

Mol Genet Metab. 2008 Jun;94(2):212-21. doi: 10.1016/j.ymgme.2008.02.004. Epub 2008 Mar 18.

15.

Development of a clinical assay for detection of GAA mutations and characterization of the GAA mutation spectrum in a Canadian cohort of individuals with glycogen storage disease, type II.

McCready ME, Carson NL, Chakraborty P, Clarke JT, Callahan JW, Skomorowski MA, Chan AK, Bamforth F, Casey R, Rupar CA, Geraghty MT.

Mol Genet Metab. 2007 Dec;92(4):325-35. Epub 2007 Aug 27.

PMID:
17723315
16.

Expression and characterization of 14 GLB1 mutant alleles found in GM1-gangliosidosis and Morquio B patients.

Santamaria R, Chabás A, Callahan JW, Grinberg D, Vilageliu L.

J Lipid Res. 2007 Oct;48(10):2275-82. Epub 2007 Jul 30.

17.

Lysosomal membranes from beige mice contain higher than normal levels of endoplasmic reticulum proteins.

Zhang H, Fan X, Bagshaw RD, Zhang L, Mahuran DJ, Callahan JW.

J Proteome Res. 2007 Jan;6(1):240-9.

PMID:
17203968
18.

Diagnosis of Krabbe disease by use of a natural substrate.

Callahan JW, Skomorowski MA.

Methods Mol Biol. 2006;347:321-30.

PMID:
17072020
19.

Identification of the gene encoding the enzyme deficient in mucopolysaccharidosis IIIC (Sanfilippo disease type C).

Fan X, Zhang H, Zhang S, Bagshaw RD, Tropak MB, Callahan JW, Mahuran DJ.

Am J Hum Genet. 2006 Oct;79(4):738-44. Epub 2006 Aug 23.

20.

The Arf-family protein, Arl8b, is involved in the spatial distribution of lysosomes.

Bagshaw RD, Callahan JW, Mahuran DJ.

Biochem Biophys Res Commun. 2006 Jun 16;344(4):1186-91. Epub 2006 Apr 19.

PMID:
16650381
21.

A comparative study of cytoplasmic granules imaged by the real-time microscope, Nile Red and Filipin in fibroblasts from patients with lipid storage diseases.

Pham NA, Gal MR, Bagshaw RD, Mohr AJ, Chue B, Richardson T, Callahan JW.

J Inherit Metab Dis. 2005;28(6):991-1004.

PMID:
16435192
23.

Lysosomal membrane proteomics and biogenesis of lysosomes.

Bagshaw RD, Mahuran DJ, Callahan JW.

Mol Neurobiol. 2005 Aug;32(1):27-41. Review.

PMID:
16077181
24.

Identification of the hydrophobic glycoproteins of Caenorhabditis elegans.

Fan X, She YM, Bagshaw RD, Callahan JW, Schachter H, Mahuran DJ.

Glycobiology. 2005 Oct;15(10):952-64. Epub 2005 May 11.

PMID:
15888633
25.

Sulfatide and Na+-K+-ATPase: a salinity-sensitive relationship in the gill basolateral membrane of rainbow trout.

Lingwood D, Fisher LJ, Callahan JW, Ballantyne JS.

J Membr Biol. 2004 Sep 15;201(2):77-84.

PMID:
15630545
26.

A proteomic analysis of lysosomal integral membrane proteins reveals the diverse composition of the organelle.

Bagshaw RD, Mahuran DJ, Callahan JW.

Mol Cell Proteomics. 2005 Feb;4(2):133-43. Epub 2004 Dec 2.

27.

A method for proteomic identification of membrane-bound proteins containing Asn-linked oligosaccharides.

Fan X, She YM, Bagshaw RD, Callahan JW, Schachter H, Mahuran DJ.

Anal Biochem. 2004 Sep 1;332(1):178-86.

PMID:
15301963
29.

Membrane-associated estrogen receptor and caveolin-1 are present in central nervous system myelin and oligodendrocyte plasma membranes.

Arvanitis DN, Wang H, Bagshaw RD, Callahan JW, Boggs JM.

J Neurosci Res. 2004 Mar 1;75(5):603-13.

PMID:
14991836
30.

Presenilin-1, nicastrin, amyloid precursor protein, and gamma-secretase activity are co-localized in the lysosomal membrane.

Pasternak SH, Bagshaw RD, Guiral M, Zhang S, Ackerley CA, Pak BJ, Callahan JW, Mahuran DJ.

J Biol Chem. 2003 Jul 18;278(29):26687-94. Epub 2003 May 7.

31.

Functional post-translational proteomics approach to study the role of N-glycans in the development of Caenorhabditis elegans.

Schachter H, Chen S, Zhang W, Spence AM, Zhu S, Callahan JW, Mahuran DJ, Fan X, Bagshaw RD, She YM, Rosa JC, Reinhold VN.

Biochem Soc Symp. 2002;(69):1-21. Review.

PMID:
12655770
32.

Nicastrin is a resident lysosomal membrane protein.

Bagshaw RD, Pasternak SH, Mahuran DJ, Callahan JW.

Biochem Biophys Res Commun. 2003 Jan 17;300(3):615-8.

PMID:
12507492
33.

Novel mutations (Asn 484 Lys, Thr 500 Ala, Gly 438 Glu) in Morquio B disease.

Bagshaw RD, Zhang S, Hinek A, Skomorowski MA, Whelan D, Clarke JT, Callahan JW.

Biochim Biophys Acta. 2002 Dec 12;1588(3):247-53.

34.
36.

Characterization of beta-galactosidase mutations Asp332-->Asn and Arg148-->Ser, and a polymorphism, Ser532-->Gly, in a case of GM1 gangliosidosis.

Zhang S, Bagshaw R, Hilson W, Oho Y, Hinek A, Clarke JT, Callahan JW.

Biochem J. 2000 Jun 15;348 Pt 3:621-32.

37.
39.

Early-infantile galactosialidosis: prenatal presentation and postnatal follow-up.

Patel MS, Callahan JW, Zhang S, Chan AK, Unger S, Levin AV, Skomorowski MA, Feigenbaum AS, O'Brien K, Hellmann J, Ryan G, Velsher L, Chitayat D.

Am J Med Genet. 1999 Jul 2;85(1):38-47.

PMID:
10377011
40.
41.

Macrophage phagocytosis of polyethylene particulate in vitro.

Voronov I, Santerre JP, Hinek A, Callahan JW, Sandhu J, Boynton EL.

J Biomed Mater Res. 1998 Jan;39(1):40-51.

PMID:
9429095
42.

Maturation and degradation of beta-galactosidase in the post-Golgi compartment are regulated by cathepsin B and a non-cysteine protease.

Okamura-Oho Y, Zhang S, Callahan JW, Murata M, Oshima A, Suzuki Y.

FEBS Lett. 1997 Dec 15;419(2-3):231-4.

43.

Identification of Glu-268 as the catalytic nucleophile of human lysosomal beta-galactosidase precursor by mass spectrometry.

McCarter JD, Burgoyne DL, Miao S, Zhang S, Callahan JW, Withers SG.

J Biol Chem. 1997 Jan 3;272(1):396-400.

44.
45.

Late-onset Tay-Sachs disease presenting as catatonic schizophrenia: diagnostic and treatment issues.

Rosebush PI, MacQueen GM, Clarke JT, Callahan JW, Strasberg PM, Mazurek MF.

J Clin Psychiatry. 1995 Aug;56(8):347-53. Review.

PMID:
7635850
46.

Kinetic mechanism and characterization of human beta-galactosidase precursor secreted by permanently transfected Chinese hamster ovary cells.

Zhang S, McCarter JD, Okamura-Oho Y, Yaghi F, Hinek A, Withers SG, Callahan JW.

Biochem J. 1994 Nov 15;304 ( Pt 1):281-8.

47.

Homozygous presence of the crossover (fusion gene) mutation identified in a type II Gaucher disease fetus: is this analogous to the Gaucher knock-out mouse model?

Strasberg PM, Skomorowski MA, Warren IB, Hilson WL, Callahan JW, Clarke JT.

Biochem Med Metab Biol. 1994 Oct;53(1):16-21.

PMID:
7857677
48.

Classification of disorders of GM2 ganglioside hydrolysis using 3H-GM2 as substrate.

Novak A, Callahan JW, Lowden JA.

Biochim Biophys Acta. 1994 Mar 2;1199(2):215-23. Erratum in: Biochim Biophys Acta 1995 Apr 13;1243(3):557.

PMID:
8123671
49.

The biochemistry and clinical features of galactosialidosis.

Okamura-Oho Y, Zhang S, Callahan JW.

Biochim Biophys Acta. 1994 Feb 22;1225(3):244-54. Review.

PMID:
8312369
50.

Nerve biopsy findings in Niemann-Pick type II (NPC)

Hahn AF, Gilbert JJ, Kwarciak C, Gillett J, Bolton CF, Rupar CA, Callahan JW.

Acta Neuropathol. 1994;87(2):149-54.

PMID:
8171965

Supplemental Content

Loading ...
Support Center